Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03302312 · ClinicalTrials.gov registry record
Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Acceptability
A clinical trial, sponsored by RTI International.
- Completed
- Registry status
- 54
- Enrollment target
NCT03302312 is a clinical trial that has completed, run by RTI International. The registered enrollment target is 54 participants.
The verdict
NCT03302312 has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
This qualitative study will use focus groups, small group interviews, and individual interviews (both in person and over the phone) to compile a range of perspectives on service members' decision-making processes and information needs related to Stellate Ganglion Block (SGB). Participants will include service members, spouses, and providers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-11-03 |
| Est. Completion | 2018-03-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03302312
The ClinicalTrials.gov registry entry for NCT03302312 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03302312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03302312 about?
NCT03302312 is a clinical study titled "Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Acceptability". This qualitative study will use focus groups, small group interviews, and individual interviews (both in person and over the phone) to compile a range of perspectives on service members' decision-making processes and information needs related to Stellate Ganglion Block (SGB). Participants will inclu...
What is the current status of trial NCT03302312?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-11-03. Estimated completion is 2018-03-02.
Who is sponsoring clinical trial NCT03302312?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.